Satellite Biosciences, Inc.
CAMBRIDGE, MA · Founded 2019 · CIK 0001832180 · Biotech · Private
Engineered cells and cell therapies for treating difficult-to-address diseases
satellite.bio →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $101M
- 2 Form D · Mar 2022
- 55 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 37
- 0 granted · 37 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓202020212022
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $19,000,000 | |
| Private capital raised | Form D · SEC | $82,470,989 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1254 | MIND BIOSCIENCES LLC | — | — |
| 1255 | TScan Therapeutics | — | $123M |
| 1256 | Aardvark Therapeutics, Inc. | — | $103M |
| 1257 | Satellite Biosciences, Inc. | — | $101M |
| 1258 | GPN THERAPEUTICS, INC. | — | — |
| 1259 | AYTU BIOSCIENCE, INC | — | $26M |
| 1260 | NANODESK, LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Sangeeta BhatiaPromoter
- Sujata BhatiaDirector
- Christopher ChenDirector · Promoter
- Laura Lande-DinerExecutive Officer
- David LennonDirector · Executive Officer
- Thomas LoweryExecutive Officer
- Diane MarcouExecutive Officer
- Eileen McGuireDirector
- Ellie McGuireDirector
- Yair SchindelDirector
- Ling WongDirector
- William YoungDirector
Patents
- Culture Media And Conditions For In Vitro Expansion Of Hepatocytesapplication
- Culture Media And Conditions For In Vitro Expansion And/or Maturation Of Hepatocytesapplication
- Engineered Tissue Constructs For The Treatment Of Hyperammonemiaapplication
- Devices And Methods For Cell Aggregationapplication
- Devices And Methods For Cell Encapsulationapplication
- Methods Of Implanting Engineered Tissue Constructsapplication
- Methods For Aggregating Cells In Suspensionapplication
- Engineered Tissue Constructs And Uses Thereofapplication
- Methods Of Implanting Engineered Tissue Constructsapplication
- Hypoimmunogenic Cell Mixtures And Methods Of Use Thereofapplication
- Devices And Methods For Cell Encapsulationapplication
- Devices And Methods For Cell Aggregationapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.